Gencove grabs $10m Series A
Gencove, a low-pass genome sequencing platform company, has secured $10 million in Series A funding.
Gencove, a low-pass genome sequencing platform company, has secured $10 million in Series A funding.
Copyright PEI Media
Not for publication, email or dissemination